Indication · General & Plastic Surgery
Hair loss
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
99
Cleared or approved since 2000
PMA and De Novo
0
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
19
126 device trials in all
Devices
99 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Hairmax Lasercomb
Lexington International, LLC · 510(k) · Laser, Comb, Hair · newest 2011 · 5 decisions
59 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- SCALp Cooling for pReventing aLopecia With nEw anTibody-drug ConjugatesPivotal-lookingRecruiting
Jules Bordet InstituteAcademic, hospital or other
NCT07474558 · 102 participants (planned) · Start Oct 23, 2026 · Primary completion Jan 15, 2030
Device: scalp cooling · For: Advanced or Metastatic Solid Tumour; Antibody-Drug Conjugate; Alopecia
Sites: Anderlecht, Belgium; Mons, Belgium; Namur, Belgium
125 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on androgenetic alopecia across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.